Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements
Krabbe disease (KD) is part of newborn screening (NBS) in 11 states with at least one additional state preparing to screen. In July 2021, KD was re-nominated for addition to the federal Recommended Uniform Screening Panel (RUSP) in the USA with a two-tiered strategy based on psychosine (PSY) as the...
Saved in:
Main Authors: | Dietrich Matern (Author), Khaja Basheeruddin (Author), Tracy L. Klug (Author), Gwendolyn McKee (Author), Patricia U. Edge (Author), Patricia L. Hall (Author), Joanne Kurtzberg (Author), Joseph J. Orsini (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn Screening for Krabbe Disease-Illinois Experience: Role of Psychosine in Diagnosis of the Disease
by: Khaja Basheeruddin, et al.
Published: (2021) -
Low Psychosine in Krabbe Disease with Onset in Late Infancy: A Case Report
by: Camille S. Corre, et al.
Published: (2021) -
Newborn Screening for Krabbe Disease and Other Lysosomal Storage Disorders: Broad Lessons Learned
by: Joseph J. Orsini, et al.
Published: (2017) -
Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease
by: Zackary Herbst, et al.
Published: (2020) -
Peripheral Neuropathy in Krabbe's Disease
by: J Gordon Millichap
Published: (1997)